| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 95.39B | 95.49B | 90.57B | 83.84B | 81.49B | 69.97B |
| Gross Profit | 15.00B | 15.57B | 14.36B | 12.63B | 12.29B | 6.96B |
| EBITDA | 10.24B | 11.83B | 9.79B | 7.56B | 8.02B | 2.73B |
| Net Income | 2.44B | 3.79B | 3.85B | 1.59B | 2.79B | -1.87B |
Balance Sheet | ||||||
| Total Assets | 140.65B | 148.54B | 131.61B | 121.14B | 104.86B | 96.50B |
| Cash, Cash Equivalents and Short-Term Investments | 17.38B | 22.19B | 25.34B | 23.60B | 15.88B | 17.47B |
| Total Debt | 40.73B | 44.23B | 37.40B | 38.05B | 29.90B | 26.13B |
| Total Liabilities | 64.20B | 67.11B | 58.69B | 62.36B | 50.39B | 44.98B |
| Stockholders Equity | 74.22B | 79.11B | 70.81B | 56.85B | 52.72B | 48.04B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -9.21B | -6.53B | -520.00M | -3.77B | -364.00M |
| Operating Cash Flow | 0.00 | 9.06B | 9.44B | 6.25B | 2.48B | 3.42B |
| Investing Cash Flow | 0.00 | -18.75B | -14.21B | -6.60B | -6.11B | -3.19B |
| Financing Cash Flow | 0.00 | 4.70B | 5.38B | 6.91B | 1.57B | 1.16B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥40.19B | 5.59 | ― | 3.75% | 2.98% | -56.70% | |
70 Outperform | ¥40.23B | 10.46 | ― | 4.53% | -2.57% | 3.43% | |
67 Neutral | ¥4.17T | 15.03 | ― | 1.41% | 7.73% | -1.93% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
60 Neutral | ¥135.02B | 11.45 | ― | 2.18% | -0.93% | -45.03% | |
56 Neutral | ¥630.45B | 15.62 | ― | 2.57% | 4.81% | -49.43% | |
47 Neutral | ¥41.14B | 9.09 | 2.26% | ― | -2.53% | -85.61% |